Daclatasvir dihydrochloride
CAS: 1009119-65-6
Rif. TM-T1786
1g | 238,00 € | ||
5mg | 41,00 € | ||
10mg | 50,00 € | ||
25mg | 60,00 € | ||
50mg | 70,00 € | ||
100mg | 80,00 € | ||
500mg | 167,00 € | ||
1ml*10 (DMSO) | 52,00 € |
Informazioni sul prodotto
- BMS-790052 dihydrochloride
- Bms 790052-05
- Carbamic acid, N,N′-[[1,1′-biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C′-dimethyl ester, hydrochloride (1:2)
- Daclatasvir.2HCL
- Daklinza
- N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically apparent liver injury with jaundice.
Proprietà chimiche
Richiesta tecnica su: TM-T1786 Daclatasvir dihydrochloride
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.